Massive cardiac thrombosis in a patient with Sheehan's syndrome

Endocrine Journal

Volumn 52, Issue 6, 2005, Pages 709-714

  Tanriverdi, Fatih ^a   Gül, Ali ^a   Gül, Ibrahim ^a   Eryol, Namik Kemal ^a   Unluhizarci, Kursad ^a   Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Cardiac thrombosis; Coagulation system; Growth hormone (GH); Growth hormone deficiency (GHD); Sheehan's syndrome

Indexed keywords

BIOLOGICAL MARKER; D DIMER; SALICYLIC ACID; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; GROWTH HORMONE DEFICIENCY; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART RIGHT ATRIUM; HEMOSTASIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOPITUITARISM; INTENSIVE CARE UNIT; INTRACARDIAC THROMBOSIS; LUNG EDEMA; MITRAL VALVE REGURGITATION; T WAVE INVERSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FUNCTION; BLOOD COAGULATION; CORONARY THROMBOSIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; FEMALE; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOPITUITARISM; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PULMONARY EDEMA; RISK FACTORS; VENTRICULAR FUNCTION;

EID: 30844436819     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.709     Document Type: Article

References (28)

1. McCallum RW, Petrie JR, Dominiczak AF, Connell JM (2002) Growth hormone deficiency and vascular risk. Clin Endocrinol (Oxf) 57: 11-24.
2. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH (1991) Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 70: 695-700.
3. Binnerts A, Deurenberg P, Swart GR, Wilson JH, Lamberts SW (1992) Body composition in growth hormone-deficient adults. Am J Clin Nutr 55: 918-923.
4. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA (1995) Growth hormone-deficient adults are insulin-resistant. Metabolism 44: 1126-1129.
5. Russell-Jones DL, Weissberger AJ, Watts GF (1994) The effects of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficiency. Endocrinol Metab 1 (Suppl).
6. Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA (1996) Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb Haemost 76: 422-428.
7. Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M (2000) Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp Clin Endocrinol Diabetes 108: 486-492.
8. Sheehan HL (1937) Postpartum necrosis of the anterior pituitary. J Pathol 45: 189-214.
9. Kelestimur F (2003) Sheehan's syndrome. Pituitary 6: 181-188.
10. Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, Arvat E, Camanni F, Ghigo E (2000) Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 142: 347-352.
11. Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336: 285-288.
12. Kelestimur F (1992) Hyperprolactinemia in a patient with Sheehan's syndrome. South Med J 85: 1008-1010.
13. Kelestimur F (1995) GH deficiency and the degree of hypopituitarism. Clin Endocrinol (Oxf) 42: 443-444.
14. Ohlson LO, Larsson B, Svardsudd K (1985) The influence of body fat distribution on the incidence of diabetes mellitus. Diabetes 34: 1055-1058.
15. Ostrander LD, Brandt RL, Kjelsberg MO, Epstein FH (1965) Electrocardiographic findings among the adult population of a total natural community, tecumseh, michigan. Circulation 31: 888-898.
16. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A (1999) Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 99: 3028-3035.
17. Aschenberg W, Schluter M, Kremer P, Schroder E, Siglow V, Bleifeld W (1986) Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 7: 163-166.
18. Manning WJ, Leeman DE, Gotch PJ, Come PC (1989) Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13: 617-623.
19. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Salcedo EE, Klein AL (1993) Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol 22: 1359-1366.
20. Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23: 961-969.
21. Hwang JJ, Shyu KG, Hsu KL, Chen JJ, Kuan P, Lien WP (1994) Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism. Chest 106: 8-12.
22. Movsowitz C, Movsowitz HD, Jacobs LE, Meyerowitz CB, Podolsky LA, Kotler MN (1993) Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. J Am Soc Echocardiogr 6: 107-114.
23. Blackshear JL, Pearce LA, Asinger RW, Dittrich HC, Goldman ME, Zabalgoitia M, Rothbart RM, Halperin JL (1993) Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with non-rheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 72: 840-843.
24. Johansson JO, Landin K, Tengborn L, Rosen T, Bengtsson BA (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 14: 434-437.
25. Kvasnicka J, Marek J, Kvasnicka T, Weiss V, Markova M, Stepan J, Umlaufova A (2000) Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin Endocrinol (Oxf) 52: 543-548.
26. Ishizu A, Shimizu C, Tsuji T, Nagai S, Yoshiki T (2004) Peripheral pulmonary embolism related to a thrombus of the inferior vena cava triggering fatal adrenal crisis in Sheehan's syndrome. Endocr J 51: 387-388.
27. Blann AD, Morris J, McCollum CN (1996) Soluble L-selectin in atherosclerosis: relationship to soluble E-selectin and soluble P-selectin. Atherosclerosis 126: 227-231.
28. Marek J, Kvasnicka J, Weiss V, Markova M, Hass T (1998) [Can normalization of vascular cytoadhesive activity be explained by the anti-atherosclerosis effect of growth hormone?]. Cas Lek Cesk 137: 690-693.